JPMorgan Makes Winning Calls, Says Continue to Buy Chip Stocks
JPMorgan thinks that 2016 looks better for chips and chip equipment, and given the rough 2015, it is a good-looking sector valuewise.
JPMorgan thinks that 2016 looks better for chips and chip equipment, and given the rough 2015, it is a good-looking sector valuewise.
The UBS focus on buying good stocks at a good value makes even more sense now than ever.
Six words that nobody ever likes to hear uttered -- "this time it may be different" -- may just make sense now.
The bottom line is volatility at higher levels may be here to stay for some time. Owning low-multiple, dividend-paying blue chip leaders makes good sense for long-term growth portfolios.
While the UBS Dividend Rulers portfolio has underperformed so far this year, it is very possibly a function of the market overestimating the timing and extent of interest rates increases.
In a new report, Jefferies is out with three very good new growth stock ideas for investors. Two of the picks are aggressive biotech and medical device plays, and one a leading retailer.
Stifel points to four specific semiconductor stocks it feels currently trade at relatively attractive valuations. All are rated Buy at the firm as well.
Oppenheimer makes it clear it thinks change is on the way and a EMC/Dell combination could spark a consolidation trend across the sector.
These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.
In a new Deutsche Bank research report, while Buy ratings are kept on three top stock picks, price targets are slashed on all the sector leaders.
In a new research report, Merrill Lynch cuts earnings estimates and price targets an average 4% across the firm's 41 banks in their coverage universe.
While insider buying remains consistent, it does appear that the windows for executives and 10% owners to buy and sell are starting to shut ahead of earnings.
Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.
Cloud computing continues to grow almost unabated, and these Deutsche Bank stock picks give aggressive investors numerous ways to play this incredible technology trend.
For patient long-term investors, these two MLPs may provide solid distributions during the wait for a rebound in energy pricing.
We scanned the Merrill Lynch stock coverage universe for specialty pharmaceutical stocks rated Buy and found three top companies that have been crushed.
These Jefferies stocks to buy are spread across multiple sectors and offer growth accounts solid investments for the short and long term.
In a new report, SunTrust Robinson Humphrey features stock picks that are designed to help clients "catch up" to their benchmarks.
The fourth quarter often offers seasonal upside, especially in a year when all the indexes are still negative, and Oppenheimer says it may be smart to buy any weakness in the coming weeks.
One good area for investors to look now is value, and a new report from Jefferies highlights some stocks that investors may not perceive as true value companies.